The Unified Protocol for the Treatment of Emotional Disorders in Spanish Public Mental Health System
Launched by UNIVERSITAT JAUME I · Feb 22, 2017
Trial Information
Current as of May 08, 2025
Unknown status
Keywords
ClinConnect Summary
Emotional disorders (EDs; i.e., depressive and anxiety disorders) have become the most prevalent psychiatric disorders globally. The 12-month prevalence of anxiety and depressive disorders affect 14% and 7.8% (6.9% by major depression) of the population, respectively, and comordibity may be as high as 50%. Lifetime prevalence rates in primary care settings in Spain reveal that mood and anxiety disorders, as defined in the DSM-IV-TR, are the most prevalent psychiatric problems as well, with 35.8% and 25.6%, respectively.
As a result of their high prevalence in the population, emotional diso...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Anxiety or mood disorder is the main diagnosis
- • The patient is over 18 years of age
- • The patient is fluent in the language in which the therapy is performed (Spanish in the present study)
- • The patient is able to attend to the evaluation and treatment sessions
- • The patient signs the informed consent form
- Exclusion Criteria:
- • The patient presents a severe mental disorder (bipolar disorder, schizophrenia, or an organic mental disorder) or there is suicide risk at the time of assessment
- • The patient has used substances in the last three months (excluding cannabis, coffee, and / or nicotine)
- • The patient has previously received 8 or more sessions of psychological treatment with clear and identifiable CBT principles
About Universitat Jaume I
Universitat Jaume I (UJI) is a leading academic institution located in Spain, dedicated to advancing knowledge and innovation through research and education. With a strong emphasis on interdisciplinary collaboration, UJI conducts clinical trials aimed at addressing pressing health challenges and improving patient outcomes. The university's commitment to ethical standards and rigorous scientific methodologies ensures the integrity and reliability of its research endeavors. By fostering partnerships with healthcare professionals and industry stakeholders, UJI aims to translate research findings into practical applications that benefit society.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Elda, , Spain
Pamplona, , Spain
Vinaroz, , Spain
Patients applied
Trial Officials
Jorge Osma, Ph.D.
Principal Investigator
Assistant Professor
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials